Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer.

MLA

Banna, Giuseppe L., et al. “Adherence to Abiraterone or Enzalutamide in Elderly Metastatic Castration-Resistant Prostate Cancer.” Supportive Care in Cancer, vol. 28, no. 10, Oct. 2020, pp. 4687–95. EBSCOhost, https://doi.org/10.1007/s00520-020-05311-5.

APA

Banna, G. L., Urzia, V., Benanti, C., Pitrè, A., Lipari, H., Di Quattro, R., De Giorgi, U., Schepisi, G., Basso, U., Bimbatti, D., Rundo, F., Libra, M., & Malatino, L. (2020). Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer. Supportive Care in Cancer, 28(10), 4687–4695. https://doi.org/10.1007/s00520-020-05311-5

Chicago

Banna, Giuseppe L., Valeria Urzia, Chiara Benanti, Alessandra Pitrè, Helga Lipari, Rosario Di Quattro, Ugo De Giorgi, et al. 2020. “Adherence to Abiraterone or Enzalutamide in Elderly Metastatic Castration-Resistant Prostate Cancer.” Supportive Care in Cancer 28 (10): 4687–95. doi:10.1007/s00520-020-05311-5.